@article{da4b8185659742d38e30c793a94d2d1e,
title = "Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities",
keywords = "Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, Estrogen, Gonadal hormones, Racial disparities, Sex disparity",
author = "Kristina Montemayor and Raksha Jain",
note = "Funding Information: K. Montemayor receives funding from the CF Foundation ( MONTEMQ020 ), none of which is related to the content of this article. R. Jain receives consulting fees from Boehringer Ingelheim, Gilead Sciences, and Vertex Pharmaceuticals, none of which are related to the content of this article. Funding Information: K. Montemayor receives funding from the CF Foundation (MONTEMQ020), none of which is related to the content of this article. R. Jain receives consulting fees from Boehringer Ingelheim, Gilead Sciences, and Vertex Pharmaceuticals, none of which are related to the content of this article.",
year = "2022",
month = nov,
doi = "10.1016/j.mcna.2022.07.005",
language = "English (US)",
volume = "106",
pages = "1001--1012",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "6",
}